The Competition Bureau announced that it reached an agreement with Evonik Industries to address competition concerns related to its proposed acquisition of PeroxyChem.
Following an extensive review, the Bureau concluded that Evonik’s acquisition of PeroxyChem was likely to result in a substantial lessening of competition in the supply of hydrogen peroxide in Western Canada.
To remedy this concern, Evonik has agreed to sell PeroxyChem’s hydrogen peroxide manufacturing facility located in Prince George, British Columbia and related assets to a buyer acceptable to the Commissioner of Competition.
Under the agreement registered with the Competition Tribunal, Evonik has proposed United Initiators (UI) as the buyer of this facility. The Commissioner reviewed UI’s suitability and concluded that they are an acceptable buyer.
The Bureau is satisfied that this agreement will preserve competition in Western Canada’s hydrogen peroxide market.
Full Content: Canada
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
FTC Urged to Enforce Rarely Used Antitrust Law Against Retail Giants
Mar 28, 2024 by
CPI
UK’s Fingleton Bolsters Team with New Additions
Mar 28, 2024 by
CPI
Britain’s Competition Regulator Clears Aviva’s Acquisition of AIG Life UK
Mar 28, 2024 by
CPI
White House Implements New AI Safeguards to Protect Rights and Safety
Mar 28, 2024 by
CPI
Denver Court Sets August Date for Kroger-Albertsons Merger Showdown
Mar 28, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Real Estate & Antitrust
Mar 27, 2024 by
CPI
Systematic National Evidence of Steering by Real Estate Agents
Mar 27, 2024 by
CPI
Compliance Now! Actionable Antitrust Advice for the Residential Real Estate Industry
Mar 27, 2024 by
CPI
Real Estate Commissions: Some Insights from the Economics of Multi-Sided Platforms
Mar 27, 2024 by
CPI
New Ideas for Promoting Real Estate Brokerage Price Competition
Mar 27, 2024 by
CPI